These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1376852)

  • 1. Haemolytic uraemic syndrome during FK506 therapy.
    Ichihashi T; Naoe T; Yoshida H; Kiyoi H; Fukutani H; Kubo K; Yamauchi T; Saito H; Ohno R
    Lancet; 1992 Jul; 340(8810):60-1. PubMed ID: 1376852
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemolytic-uraemic syndrome after tacrolimus rescue therapy for cortisone-resistant rejection.
    Schmidt RH; Lenz T; Gröne HJ; Geiger H; Scheuermann EH
    Nephrol Dial Transplant; 1999 Apr; 14(4):979-83. PubMed ID: 10328486
    [No Abstract]   [Full Text] [Related]  

  • 3. The successful conversion to Tacrolimus (FK506) of a renal transplant recipient with cyclosporin-induced haemolytic-uraemic syndrome.
    Richardson D; Jones CH; Newstead CG; Will EJ; Lodge JP
    Nephrol Dial Transplant; 1996 Dec; 11(12):2498-500. PubMed ID: 9017633
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
    Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA
    Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506.
    McCauley J; Bronsther O; Fung J; Todo S; Starzl TE
    Lancet; 1989 Dec 23-30; 2(8678-8679):1516. PubMed ID: 2481200
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of transplant renal artery thrombosis and signs of haemolytic-uraemic syndrome following the change from cyclosporin to tacrolimus in a renal transplant patient.
    Kiykim AA; Ozer C; Yildiz A; Tiftik N; Senli M; Kelebek E; Doruk E; Akbay E
    Nephrol Dial Transplant; 2004 Oct; 19(10):2653-6. PubMed ID: 15388824
    [No Abstract]   [Full Text] [Related]  

  • 7. Eye Movement Disorders Following Allogeneic Bone Marrow Transplantation on FK506 (Tacrolimus) and Ganciclovir.
    Karagun BS; Akbas T; Arpaci T; Antmen B
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):71-73. PubMed ID: 28731920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation.
    Walder B; Ricou B; Suter PM
    J Heart Lung Transplant; 1998 Oct; 17(10):1004-6. PubMed ID: 9811409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical calcineurin inhibitor-induced haemolytic uremic syndrome after liver transplantation.
    Furmańczyk A; Komuda-Leszek E; Durlik M
    Ann Transplant; 2009; 14(4):47-51. PubMed ID: 20009155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report.
    Neto P; Lopes K; Macário F; Alves R; Mota A; Campos M
    Nefrologia; 2013 Jan; 33(1):152-4. PubMed ID: 23364650
    [No Abstract]   [Full Text] [Related]  

  • 11. FK-506 and haemolytic uraemic syndrome.
    Brown Z; Neild GH
    Lancet; 1990 Feb; 335(8686):412. PubMed ID: 1689442
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation--is tacrolimus the answer?
    Grupp C; Schmidt F; Braun F; Lorf T; Ringe B; Müller GA
    Nephrol Dial Transplant; 1998 Jul; 13(7):1629-31. PubMed ID: 9681701
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.
    Pratap B; Abraham G; Srinivas CN; Bhaskar S
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
    Boctor FN
    Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus-associated hemolytic uremic syndrome in a pediatric heart transplant recipient.
    Gray JM; Ameduri RK
    Pediatr Transplant; 2016 Sep; 20(6):866-7. PubMed ID: 27371345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient.
    Shitrit D; Starobin D; Aravot D; Fink G; Izbicki G; Kramer M
    Transplant Proc; 2003 Mar; 35(2):627-8. PubMed ID: 12644073
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression.
    Schmidt RJ; Venkat KK; Dumler F
    Transplant Proc; 1991 Dec; 23(6):3156-7. PubMed ID: 1721390
    [No Abstract]   [Full Text] [Related]  

  • 18. Tacrolimus-associated hemolytic uremic syndrome: a case analysis.
    Lin CC; King KL; Chao YW; Yang AH; Chang CF; Yang WC
    J Nephrol; 2003; 16(4):580-5. PubMed ID: 14696762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation.
    Koehler MT; Howrie D; Mirro J; Neudorf S; Blatt J; Corey S; Wollman M; Kelly-Ekeroth V; Reyes J
    Bone Marrow Transplant; 1995 Jun; 15(6):895-9. PubMed ID: 7581088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin-induced haemolytic-uraemic syndrome presenting as primary graft dysfunction.
    Kohli HS; Sud K; Jha V; Gupta KL; Minz M; Joshi K; Sakhuja V
    Nephrol Dial Transplant; 1998 Nov; 13(11):2940-2. PubMed ID: 9829509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.